PubMed

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy.

Forbes JM, Cooper ME, Thallas V, Burns WC, Thomas MC, Brammar GC, Lee F, Grant SL, Burrell LA, Jerums G, Osicka TM.

Diabetes. 2002 Nov;51(11):3274-82. Erratum in: Diabetes 2002 Dec;51(12):3592. PMID: 12401719 [PubMed - indexed for MEDLINE]Related articlesFree article

Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?

Coughlan MT, Thallas-Bonke V, Pete J, Long DM, Gasser A, Tong DC, Arnstein M, Thorpe SR, Cooper ME, Forbes JM.

Endocrinology. 2007 Feb;148(2):886-95. Epub 2006 Nov 16.PMID: 17110423 [PubMed - indexed for MEDLINE]Related articlesFree article

Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.

Soulis T, Cooper ME, Sastra S, Thallas V, Panagiotopoulos S, Bjerrum OJ, Jerums G.

Diabetologia. 1997 Oct;40(10):1141-51.PMID: 9349594 [PubMed - indexed for MEDLINE]Related articles

Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition.

Wihler C, Schäfer S, Schmid K, Deemer EK, Münch G, Bleich M, Busch AE, Dingermann T, Somoza V, Baynes JW, Huber J.

Diabetologia. 2005 Aug;48(8):1645-53. Epub 2005 Jul 12.PMID: 16010524 [PubMed - indexed for MEDLINE]Related articles

Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.

Forbes JM, Thorpe SR, Thallas-Bonke V, Pete J, Thomas MC, Deemer ER, Bassal S, El-Osta A, Long DM, Panagiotopoulos S, Jerums G, Osicka TM, Cooper ME.

J Am Soc Nephrol. 2005 Aug;16(8):2363-72. Epub 2005 Jun 1.PMID: 15930093 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment.

Soulis T, Cooper ME, Vranes D, Bucala R, Jerums G.

Kidney Int. 1996 Aug;50(2):627-34.PMID: 8840295 [PubMed - indexed for MEDLINE]Related articles

Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease.

Jerums G, Panagiotopoulos S, Forbes J, Osicka T, Cooper M.

Arch Biochem Biophys. 2003 Nov 1;419(1):55-62. Review.PMID: 14568009 [PubMed - indexed for MEDLINE]Related articles

Renoprotective effects of a novel inhibitor of advanced glycation.

Forbes JM, Soulis T, Thallas V, Panagiotopoulos S, Long DM, Vasan S, Wagle D, Jerums G, Cooper ME.

Diabetologia. 2001 Jan;44(1):108-14.PMID: 11206401 [PubMed - indexed for MEDLINE]Related articles

Inhibitors of advanced glycation end-products prevent loss of enteric neuronal nitric oxide synthase in diabetic rats.

Jeyabal PV, Kumar R, Gangula PR, Micci MA, Pasricha PJ.

Neurogastroenterol Motil. 2008 Mar;20(3):253-61. Epub 2007 Oct 17.PMID: 17971026 [PubMed - indexed for MEDLINE]Related articles

ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.

Wilkinson-Berka JL, Kelly DJ, Koerner SM, Jaworski K, Davis B, Thallas V, Cooper ME.

Diabetes. 2002 Nov;51(11):3283-9.PMID: 12401720 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.

Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM.

Diabetes. 2008 Feb;57(2):460-9. Epub 2007 Oct 24.PMID: 17959934 [PubMed - indexed for MEDLINE]Related articlesFree article

Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice.

Fan Q, Liao J, Kobayashi M, Yamashita M, Gu L, Gohda T, Suzuki Y, Wang LN, Horikoshi S, Tomino Y.

Nephrol Dial Transplant. 2004 Dec;19(12):3012-20.PMID: 15574998 [PubMed - indexed for MEDLINE]Related articlesFree article

Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway.

Thallas-Bonke V, Lindschau C, Rizkalla B, Bach LA, Boner G, Meier M, Haller H, Cooper ME, Forbes JM.

Diabetes. 2004 Nov;53(11):2921-30.PMID: 15504973 [PubMed - indexed for MEDLINE]Related articlesFree article

Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy?

McLennan SV, Kelly DJ, Schache M, Waltham M, Dy V, Langham RG, Yue DK, Gilbert RE.

Kidney Int. 2007 Aug;72(4):481-8. Epub 2007 Jun 6.PMID: 17554258 [PubMed - indexed for MEDLINE]Related articles

The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.

Forbes JM, Thallas V, Thomas MC, Founds HW, Burns WC, Jerums G, Cooper ME.

FASEB J. 2003 Sep;17(12):1762-4. Epub 2003 Jul 18.PMID: 12958202 [PubMed - indexed for MEDLINE]Related articlesFree article

Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.

Huang Y, Lin S, Zhou J.

Chin Med J (Engl). 1998 Aug;111(8):698-704.PMID: 11245022 [PubMed - indexed for MEDLINE]Related articles

From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy.

Miyata T, Yamamoto M, Izuhara Y.

Ann N Y Acad Sci. 2005 Jun;1043:740-9.PMID: 16037301 [PubMed - indexed for MEDLINE]Related articles

The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin-induced diabetic rats: preventive versus curative treatment.

Usta MF, Kendirci M, Gur S, Foxwell NA, Bivalacqua TJ, Cellek S, Hellstrom WJ.

J Sex Med. 2006 Mar;3(2):242-50; discussion 250-2.PMID: 16490017 [PubMed - indexed for MEDLINE]Related articles

Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine.

Roufail E, Soulis T, Boel E, Cooper ME, Rees S.

Diabetologia. 1998 Dec;41(12):1419-25.PMID: 9867208 [PubMed - indexed for MEDLINE]Related articles

Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli.

Sugimoto H, Shikata K, Wada J, Horiuchi S, Makino H.

Diabetologia. 1999 Jul;42(7):878-86.PMID: 10440132 [PubMed - indexed for MEDLINE]Related articles